The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart

Cardiovascular Research

Volumn 57, Issue 2, 2003, Pages 405-415

  Bell, Robert M ^a   Maddock, Helen L ^a   Yellon, Derek M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Free radicals; Infarction; K ATP channel; Mitochondria; Nitric oxide

Indexed keywords

DECANOIC ACID DERIVATIVE; ESTER DERIVATIVE; FREE RADICAL; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SCAVENGER; TIOPRONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HEART DEPOLARIZATION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOTONIC AGENTS; FEMALE; FREE RADICALS; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; NITRIC OXIDE DONORS; ORGAN CULTURE TECHNIQUES; PENICILLAMINE; POTASSIUM CHANNELS;

EID: 0037304475     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00675-2     Document Type: Article

References (49)

1. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
2. Gallis B., Corthals G.L., Goodlett D.R., et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J. Biol. Chem. 274:1999;30101-30108.
3. Imagawa J., Yellon D.M., Baxter G.F. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br. J. Pharmacol. 126:1999;701-708.
4. Guo Y., Jones W.K., Xuan Y.T., et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc. Natl. Acad. Sci. USA. 96:1999;11507-11512.
5. Bell R.M., Yellon D.M. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovasc. Res. 52:2001;274-280.
6. Bell R.M., Smith C.C., Yellon D.M. Nitric oxide as a mediator of delayed pharmacological (A(1) receptor triggered) preconditioning; is eNOS masquerading as iNOS? Cardiovasc. Res. 53:2002;405-413.
7. V.C. Patel, D.M. Yellon, K.J. Singh, G.H. Neild, R.G. Woolfson, Inhibition of nitric oxide limits infarct size in the in situ rabbit heart, Biochem. Biophys. Res. Commun. 194 (1993) 234-238 issn: 0006-291x.
8. Taimor G., Hofstaetter B., Piper H.M. Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia. Cardiovasc. Res. 45:2000;588-594.
9. Ishiyama S., Hiroe M., Nishikawa T., et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation. 95:1997;489-496.
10. Takahashi W., Suzuki J.I., Izawa A., et al. Inducible nitric oxide-mediated myocardial apoptosis contributes to graft failure during acute cardiac allograft rejection in mice. Jpn. Heart J. 41:2000;493-506.
11. Radi R., Rodriguez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308:1994;89-95.
12. Borutaite V., Morkuniene R., Brown G.C. Nitric oxide donors, nitrosothiols and mitochondrial respiration inhibitors induce caspase activation by different mechanisms. FEBS Lett. 467:2000;155-159.
13. Banka V.S., Bodenheimer M.M., Ramanathan K.B., Hermann G.A., Helfant R.H. Progressive transmural electrographic, myocardial potassium ion/sodium ion ratio and ultrastructural changes as a function of time after acute coronary occlusion. Am. J. Cardiol. 42:1978;429-443.
14. Jennings R.B., Schaper J., Hill M.L., Steenbergen C., Reimer K.A. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ. Res. 56:1985;262-278.
15. Lichtig C., Brooks H. Myocardial ultrastructure and function during progressive early ischemia in the intact heart. J. Thorac. Cardiovasc. Surg. 70:1975;309-315.
16. Hegstad A.C., Ytrehus K., Lindal S., Jorgensen L. Ultrastructural alterations during the critical phase of reperfusion: a stereological study in buffer-perfused isolated rat hearts. Cardiovasc. Pathol. 8:1999;279-289.
17. Shen A.C., Jennings R.B. Kinetics of calcium accumulation in acute myocardial ischemic injury. Am. J. Pathol. 67:1972;441-452.
18. Shen A.C., Jennings R.B. Myocardial calcium and magnesium in acute ischemic injury. Am. J. Pathol. 67:1972;417-440.
19. Jennings R.B., Shen A.C. Calcium in experimental myocardial ischemia. Recent Adv. Stud. Cardiac. Struct. Metab. 1:1972;639-655.
20. Allen S.P., Darley-Usmar V.M., McCormack J.G., Stone D. Changes in mitochondrial matrix free calcium in perfused rat hearts subjected to hypoxia-reoxygenation. J. Mol. Cell Cardiol. 25:1993;949-958.
21. Griffiths E.J., Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem. J. 307:1995;93-98.
22. Borutaite V., Morkuniene R., Brown G.C. Release of cytochrome c from heart mitochondria is induced by high Ca2+ and peroxynitrite and is responsible for Ca(2+)-induced inhibition of substrate oxidation. Biochim. Biophys. Acta. 1453:1999;41-48.
23. Li P., Nijhawan D., Budihardjo I., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
24. Hotta Y., Otsuka-Murakami H., Fujita M., et al. Protective role of nitric oxide synthase against ischemia-reperfusion injury in guinea pig myocardial mitochondria. Eur. J. Pharmacol. 380:1999;37-48.
25. Rakhit R.D., Mojet M.H., Marber M.S., Duchen M.R. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation. 103:2001;2617-2623.
26. Brookes P.S., Salinas E.P., Darley-Usmar K., et al. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J. Biol. Chem. 275:2000;20474-20479.
27. Holmuhamedov E.L., Wang L., Terzic A. ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J. Physiol. (Lond). 519:(Pt 2):1999;347-360.
28. 2+ overload injury in rat myocardium. Circ. Res. 84:1999;1156-1165.
29. Mizumura T., Nithipatikom K., Gross G.J. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation. 92:1995;1236-1245.
30. Sasaki N., Sato T., Ohler A., O'Rourke B., Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation. 101:2000;439-445.
31. Csont T., Szilvassy Z., Fulop F., et al. Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP. Br. J. Pharmacol. 128:1999;1427-1434.
32. Johnson N., Khan A., Virji S., Ward J.M., Crompton M. Import and processing of heart mitochondrial cyclophilin D. Eur. J. Biochem. 263:1999;353-359.
33. Ehrenberg B., Montana V., Wei M.D., Wuskell J.P., Loew L.M. Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes. Biophys. J. 53:1988;785-794.
34. Scaduto R.C., Grotyohann L.W. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys. J. 76:1999;469-477.
35. + channels. Circ. Res. 81:1997;1072-1082.
36. + channels modulate cardiac mitochondrial function. Am. J. Physiol. 275:1998;H1567-H1576.
37. Jaburek M., Yarov-Yarovoy V., Paucek P., Garlid K.D. State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate. J. Biol. Chem. 273:1998;13578-13582.
38. Carroll R., Gant V.A., Yellon D.M. Mitochondrial K(ATP) channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc. Res. 51:2001;691-700.
39. Nakano A., Liu G.S., Heusch G., Downey J.M., Cohen M.V. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J. Mol. Cell Cardiol. 32:2000;1159-1167.
40. Cheung P.Y., Danial H., Jong J., Schulz R. Thiols protect the inhibition of myocardial aconitase by peroxynitrite. Arch. Biochem. Biophys. 350:1998;104-108.
41. Cleeter M.W., Cooper J.M., Darley-Usmar V.M., Moncada S., Schapira A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett. 345:1994;50-54.
42. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 328:1996;309-316.
43. Brown G.C., Borutaite V. Nitric oxide, cytochrome c and mitochondria. Biochem. Soc. Symp. 66:1999;17-25.
44. Brookes P.S., Zhang J., Dai L., et al. Increased sensitivity of mitochondrial respiration to inhibition by nitric oxide in cardiac hypertrophy. J. Mol. Cell Cardiol. 33:2001;69-82.
45. Trochu J.N., Bouhour J.B., Kaley G., Hintze T.H. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease. Circ. Res. 87:2000;1108-1117.
46. Piantadosi C.A., Tatro L.G., Whorton A.R. Nitric oxide and differential effects of ATP on mitochondrial permeability transition. Nitric Oxide. 6:2002;45-60.
47. Pieper A.A., Verma A., Zhang J., Snyder S.H. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20:1999;171-181.
48. Di Lisa F., Menabo R., Canton M., Barile M., Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276:2001;2571-2575.
49. Beltran B., Mathur A., Duchen M.R., Erusalimsky J.D., Moncada S. The effect of nitric oxide on cell respiration: a key to understanding its role in cell survival or death. Proc. Natl. Acad. Sci. USA. 97:2000;14602-14607.